Lumexa Imaging Stock Forecast
NASDAQ: LMRIHealth CareMedical SpecialitiesUSD
Market open · Delayed 15 min · as of Oct 9, 1:33 PM ET
LMRI analyst consensus
Consensus (10 analysts)
strong_buy
Avg. price target
$17.67+67.89%
- Strong buy 2
- Buy 8
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 10 Wall Street analysts covering Lumexa Imaging (2026-10-09), 10 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $17.67, with a high estimate of $23.00 and a low estimate of $13.00. The average target implies upside of 67.9% from the current price of $10.53.
The spread between the highest and lowest targets is 76.9%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for LMRI.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 20% |
| Buy | 8 | 80% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $13.00 | +23.52% |
| Average target | $17.67 | +67.89% |
| High target | $23.00 | +118.53% |